Allegiance Financial Group Advisory Services LLC Biomarin Pharmaceutical Inc Transaction History
Allegiance Financial Group Advisory Services LLC
- $329 Billion
- Q1 2025
A detailed history of Allegiance Financial Group Advisory Services LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Allegiance Financial Group Advisory Services LLC holds 3,063 shares of BMRN stock, worth $190,089. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,063Holding current value
$190,089% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
646Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.41 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.2 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.13 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$915 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$806 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...